Methicillin-resistant Staphylococcus aureus among a network of French private-sector community-based-medical laboratories

Medecine et Maladies Infectieuses

Volumn 39, Issue 5, 2009, Pages 311-318

  Maugat, S ^a   de Rougemont, A ^b   Aubry Damon, H ^a   Reverdy, M E ^b   Georges, S ^a   Vandenesch, F ^b   Etienne, J ^b   Coignard, B ^a  

^a INSTITUT DE VEILLE SANITAIRE   (France)

^b INSERM   (France)

Author keywords

Methicillin resistance; PVL toxin; Staphylococcus aureus

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 6; PANTON VALENTINE LEUKOCIDIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; DISEASE SURVEILLANCE; FEMALE; FRANCE; HUMAN; LABORATORY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLECULAR CLONING; MORBIDITY; NONHUMAN; OUTPATIENT CARE; PRESCHOOL CHILD; SCHOOL CHILD;

BLOOD; COMMUNITY-ACQUIRED INFECTIONS; FECES; FEMALE; FRANCE; HUMANS; INCIDENCE; LABORATORIES; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OUTPATIENTS; SEX RATIO; STAPHYLOCOCCAL INFECTIONS;

EID: 67349092425     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2009.03.007     Document Type: Article

References (27)

1. Ferry T., Bes M., Dauwalder O., et al. Toxin gene content of the Lyon methicillin-resistant Staphylococcus aureus clone compared with that of other pandemic clones. J Clin Microbiol 44 (2006) 2642-2644
2. Lescure F.X., Locher G., Eveillard M., et al. Community-acquired infection with healthcare-associated methicillin-resistant Staphylococcus aureus: the role of home nursing care. Infect Control Hosp Epidemiol 27 (2006) 1213-1218
3. Vandenesch F., Naimi T., Enright M.C., et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9 (2003) 978-984
4. Robert J., Etienne J., and Bertrand X. Methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a retrospective case series from 12 French hospital laboratories, 2000-2003. Clin Microbiol Infect 11 (2005) 585-587
5. Moran G.J., Krishnadasan A., Gorwitz R.J., et al. Methicillin-resistant Staphylococcus aureus infections among patients in the emergency department. N Engl J Med 355 (2006) 666-674
6. Durand G., Bes M., Meugnier H., et al. Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxin 1 gene responsible for hospital- and community-acquired infections in France. J Clin Microbiol 44 (2006) 847-853
7. Maugat S., Maugat S., Georges S., Nicolau J., Mevel M., Moreau F., et al. Mise en œuvre d'un réseau de surveillance de la résistance bactérienne aux antibiotiques en ville : le réseau Labville. Med Mal Infect 38 (2008) 249-255
8. Jarraud S., Cozon G., Vandenesch F., Bes M., Etienne J., and Lina G. Involvement of enterotoxins G and I in staphylococcal toxic shock syndrome and staphylococcal scarlet fever. J Clin Microbiol 37 (1999) 2446-2449
9. Jarraud S., Mougel C., Thioulouse J., et al. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun 70 (2002) 631-641
10. Jarraud S., Peyrat M.A., Lim A., et al. egc, a highly prevalent operon of enterotoxin gene, forms a putative nursery of superantigens in Staphylococcus aureus. J Immunol 166 (2001) 669-677
11. CASFM. Recommandations du comité de l'antibiogramme de la Société française de microbiologie : Société française de microbiologie (SFM), 2003. http://www.sfm.asso.fr [consulted on 9th April 2009].
12. Rijks Instituut voor Volksgezondheid en Milieuhygiene (RIVM). Report 2005. 147p. European Antibiotics Resistance Surveillance System (EARSS) 2006. http://www.earss.rivm.nl [consulted on 9th April 2009].
13. Grundmann H., Aires-de-Sousa M., Boyce J., and Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368 (2006) 874-885
14. Ten Ham PGB, Nys S, Deurenberg RH, et al. Prevalence if antibiotic resistance in the community in the southern part of the Netherlands. In: International Meeting on Emerging Diseases and Surveillance 2007 (IMED 2007). Vienna, Austria, 23-25 February 2007.
15. Albertini M.T., Benoit C., Berardi L., et al. Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum beta-lactamase (ESBLE) in Northern France: a five-year multicentre incidence study. J Hosp Infect 52 (2002) 107-113
16. Carbonne A, Arnaud I, Coignard B, et al. Multidrug resistant bacteria (MDRB) surveillance, France, 2002-2005. In: 17th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Munich, Germany, 31 March-3 April 2007.
17. Abudu L., Blair I., Fraise A., and Cheng K.K. Methicillin-resistant Staphylococcus aureus (MRSA): a community-based prevalence survey. Epidemiol Infect 126 (2001) 351-356
18. Charlebois E.D., Bangsberg D.R., Moss N.J., et al. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis 34 (2002) 425-433
19. Hussain F.M., Boyle-Vavra S., Bethel C.D., and Daum R.S. Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility. Pediatr Infect Dis J 19 (2000) 1163-1166
20. Rezende N.A., Blumberg H.M., Metzger B.S., Larsen N.M., Ray S.M., and McGowan Jr. J.E. Risk factors for methicillin-resistance among patients with Staphylococcus aureus bacteremia at the time of hospital admission. Am J Med Sci 323 (2002) 117-123
21. Salgado C.D., Farr B.M., and Calfee D.P. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 36 (2003) 131-139
22. Naimi T.S., LeDell K.H., Como-Sabetti K., et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290 (2003) 2976-2984
23. Hulten K.G., Kaplan S.L., Gonzalez B.E., et al. Three-year surveillance of community onset health care-associated Staphylococcus aureus infections in children. Pediatr Infect Dis J 25 (2006) 349-353
24. Kourbatova E.V., Halvosa J.S., King M.D., Ray S.M., White N., and Blumberg H.M. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Am J Infect Control 33 (2005) 385-391
25. Saiman L., O'Keefe M., Graham III P.L., et al. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis 37 (2003) 1313-1319
26. Moran G.J., Amii R.N., Abrahamian F.M., and Talan D.A. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis 11 (2005) 928-930
27. Naimi T.S., LeDell K.H., Boxrud D.J., et al. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis 33 (2001) 990-996